Sign up USA
Alnylam Pharmaceuticals (NASDAQ:ALNY)

Alnylam Pharmaceuticals (NASDAQ:ALNY)


Share Price
$ 94.57
Change
-0.64 (-0.67 %)
Market Cap
$9,519.99 m
Proactive Investors - Run By Investors For Investors

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). The RNAi therapeutic program, ALN-RSV01, is in Phase II clinical trials for the treatment of human respiratory syncytial virus (RSV), infection.
EPIC: ALNY
Market: NASDAQ:ALNY
52-week High/Low: $153.80 / $87.35
Sector: Pharmaceuticals
Market Cap: $9,519.99M
Website: www.alnylam.com

Alnylam Pharmaceuticals

www.alnylam.com

Interactive graph

col 3
col 4
col 5
col 6

Alnylam Pharmaceuticals Timeline

Market Reports Including ALNY

VIEW ALL
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use